{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:51:13Z","timestamp":1791575473086,"version":"4.3.4"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Mental Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Minor hallucinations (MHs) affect up to 40% of patients with Parkinson\u2019s disease (PD) and are early indicators of cognitive decline. Unlike previous group-level studies, connectome-based brain fingerprinting enables the capture of individualized neural features. Leveraging this framework in a cross-sectional cohort of patients with Parkinson\u2019s disease with and without MHs using resting-state functional magnetic resonance imaging, here we show that each patient exhibits a unique brain fingerprint, irrespective of MH status. The most individualized features were associated with clinically relevant measures such as motor-symptom severity and cognitive performance. Patients with MHs showed a loss of individual-specific features in brain networks linked to cognitive health, whereas the cerebellar-to-cortex connectivity\u2014typically less distinctive\u2014became more prominent, emphasizing the role of somatosensory and motor integration in MH pathogenesis. Moreover, MH-related fingerprint regions mapped onto cortical territories with lower densities of neurotransmitter systems implicated in hallucinations. Overall, our fully data-driven findings reveal a distinct, patient-specific signature that differentiates patients with Parkinson\u2019s disease and MHs.<\/jats:p>","DOI":"10.1038\/s44220-026-00657-x","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:03:08Z","timestamp":1780909388000},"page":"1021-1034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient-specific functional networks track early cognitive alterations and minor hallucinations in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9545-3376","authenticated-orcid":false,"given":"Sara","family":"Stampacchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fosco","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2879-3861","authenticated-orcid":false,"given":"Dimitri","family":"Van De Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6705-9689","authenticated-orcid":false,"given":"Enrico","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lada","family":"Kohoutov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7958-6558","authenticated-orcid":false,"given":"John-Paul","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-704X","authenticated-orcid":false,"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9745-3983","authenticated-orcid":false,"given":"Olaf","family":"Blanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"657_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"657_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"657_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-023-00918-8","volume":"20","author":"J Pagonabarraga","year":"2024","unstructured":"Pagonabarraga, J., Bejr-Kasem, H., Martinez-Horta, S. & Kulisevsky, J. Parkinson disease psychosis: from phenomenology to neurobiological mechanisms. Nat. Rev. Neurol. 20, 135\u2013150 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"657_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma, R. B. & Berg, D. Advances in markers of prodromal Parkinson disease. Nat. Rev. Neurol. 12, 622\u2013634 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"657_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1017\/S1092852900017284","volume":"13","author":"G F\u00e9nelon","year":"2008","unstructured":"F\u00e9nelon, G. Psychosis in Parkinson\u2019s disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms. CNS Spectr. 13, 18\u201325 (2008).","journal-title":"CNS Spectr."},{"key":"657_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.22839","volume":"25","author":"G F\u00e9nelon","year":"2010","unstructured":"F\u00e9nelon, G., Soulas, T., Zenasni, F. & De Langavant, L. C. The changing face of Parkinson\u2019s disease-associated psychosis: a cross-sectional study based on the new NINDS\u2013NIMH criteria. Mov. Disord. 25, 755\u2013759 (2010).","journal-title":"Mov. Disord."},{"key":"657_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"DH Ffytche","year":"2017","unstructured":"Ffytche, D. H. et al. The psychosis spectrum in Parkinson disease. Nat. Rev. Neurol. 13, 81\u201395 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"657_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.11.018","volume":"22","author":"A Lenka","year":"2016","unstructured":"Lenka, A., Hegde, S., Jhunjhunwala, K. R. & Pal, P. K. Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson\u2019s disease: a review. Parkinsonism Relat. Disord. 22, 1\u20138 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"657_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s44220-023-00080-6","volume":"1","author":"F Bernasconi","year":"2023","unstructured":"Bernasconi, F. et al. Theta oscillations and minor hallucinations in Parkinson\u2019s disease reveal decrease in frontal lobe functions and later cognitive decline. Nat. Ment. Health 1, 477\u2013488 (2023).","journal-title":"Nat. Ment. Health"},{"key":"657_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1212\/WNL.0000000000007913","volume":"93","author":"A Lenka","year":"2019","unstructured":"Lenka, A., Pagonabarraga, J., Pal, P. K., Bejr-Kasem, H. & Kulisvesky, J. Minor hallucinations in Parkinson disease: a subtle symptom with major clinical implications. Neurology 93, 259\u2013266 (2019).","journal-title":"Neurology"},{"key":"657_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/123.4.733","volume":"123","author":"G F\u00e9nelon","year":"2000","unstructured":"F\u00e9nelon, G., Mahieux, F., Huon, R. & Zi\u00e9gler, M. Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors. Brain 123, 733\u2013745 (2000).","journal-title":"Brain"},{"key":"657_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Primers 7, 47 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"657_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00702-015-1400-x","volume":"123","author":"J Levin","year":"2016","unstructured":"Levin, J., Hasan, A. & H\u00f6glinger, G. U. Psychosis in Parkinson\u2019s disease: identification, prevention and treatment. J. Neural Transm. 123, 45\u201350 (2016).","journal-title":"J. Neural Transm."},{"key":"657_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","volume":"5","author":"NJ Diederich","year":"2009","unstructured":"Diederich, N. J., F\u00e9nelon, G., Stebbins, G. & Goetz, C. G. Hallucinations in Parkinson disease. Nat. Rev. Neurol. 5, 331\u2013342 (2009).","journal-title":"Nat. Rev. Neurol."},{"key":"657_CR15","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","volume":"75","author":"EB Forsaa","year":"2010","unstructured":"Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T. & Alves, G. What predicts mortality in Parkinson disease? A prospective population-based long-term study. Neurology 75, 1270\u20131276 (2010).","journal-title":"Neurology"},{"key":"657_CR16","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/01.wnl.0000242630.52203.8f","volume":"67","author":"JE Galvin","year":"2006","unstructured":"Galvin, J. E., Pollack, J. & Morris, J. C. Clinical phenotype of Parkinson disease dementia. Neurology 67, 1605\u20131611 (2006).","journal-title":"Neurology"},{"key":"657_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","volume":"17","author":"J Marinus","year":"2018","unstructured":"Marinus, J., Zhu, K., Marras, C., Aarsland, D. & van Hilten, J. J. Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet Neurol. 17, 559\u2013568 (2018).","journal-title":"Lancet Neurol."},{"key":"657_CR18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","volume":"48","author":"D Aarsland","year":"2000","unstructured":"Aarsland, D., Larsen, J. P., Tandberg, E. & Laake, K. Predictors of nursing home placement in Parkinson\u2019s disease: a population-based, prospective study. J. Am. Geriatr. Soc. 48, 938\u2013942 (2000).","journal-title":"J. Am. Geriatr. Soc."},{"key":"657_CR19","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1002\/ana.21455","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G., Emre, M. & Dubois, B. Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann. Neurol. 64, S81\u201392 (2008).","journal-title":"Ann. Neurol."},{"key":"657_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00320-z","volume":"8","author":"MC Gonzalez","year":"2022","unstructured":"Gonzalez, M. C., Dalen, I., Maple-Gr\u00f8dem, J., Tysnes, O.-B. & Alves, G. Parkinson\u2019s disease clinical milestones and mortality. npj Parkinsons Dis. 8, 58 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"657_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.parkreldis.2015.04.005","volume":"21","author":"A Lenka","year":"2015","unstructured":"Lenka, A., Jhunjhunwala, K. R., Saini, J. & Pal, P. K. Structural and functional neuroimaging in patients with Parkinson\u2019s disease and visual hallucinations: a critical review. Parkinsonism Relat. Disord. 21, 683\u2013691 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"657_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/mds.25554","volume":"29","author":"CG Goetz","year":"2014","unstructured":"Goetz, C. G., Vaughan, C. L., Goldman, J. G. & Stebbins, G. T. I finally see what you see: Parkinson\u2019s disease visual hallucinations captured with functional neuroimaging. Mov. Disord. 29, 115\u2013117 (2014).","journal-title":"Mov. Disord."},{"key":"657_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11910-023-01267-1","volume":"23","author":"R Bhome","year":"2023","unstructured":"Bhome, R., Thomas, G. E. C., Zarkali, A. & Weil, R. S. Structural and functional imaging correlates of visual hallucinations in Parkinson\u2019s Disease. Curr. Neurol. Neurosci. Rep. 23, 287\u2013299 (2023).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"657_CR24","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/mds.23896","volume":"26","author":"JM Shine","year":"2011","unstructured":"Shine, J. M., Halliday, G. M., Naismith, S. L. & Lewis, S. J. G. Visual misperceptions and hallucinations in Parkinson\u2019s disease: dysfunction of attentional control networks? Mov. Disord. 26, 2154\u20132159 (2011).","journal-title":"Mov. Disord."},{"key":"657_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pneurobio.2014.01.004","volume":"116","author":"JM Shine","year":"2014","unstructured":"Shine, J. M., O\u2019Callaghan, C., Halliday, G. M. & Lewis, S. J. G. Tricks of the mind: visual hallucinations as disorders of attention. Prog. Neurobiol. 116, 58\u201365 (2014).","journal-title":"Prog. Neurobiol."},{"key":"657_CR26","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1038\/npjparkd.2015.3","volume":"1","author":"JM Shine","year":"2015","unstructured":"Shine, J. M. et al. Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson\u2019s disease: a task-based fMRI study. npj Parkinsons Dis. 1, 15003 (2015).","journal-title":"npj Parkinsons Dis."},{"key":"657_CR27","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","volume":"139","author":"RS Weil","year":"2016","unstructured":"Weil, R. S. et al. Visual dysfunction in Parkinson\u2019s disease. Brain 139, 2827\u20132843 (2016).","journal-title":"Brain"},{"key":"657_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/mds.21382","volume":"22","author":"B Ravina","year":"2007","unstructured":"Ravina, B. et al. Diagnostic criteria for psychosis in Parkinson\u2019s disease: report of an NINDS, NIMH work group. Mov. Disord. 22, 1061\u20131068 (2007).","journal-title":"Mov. Disord."},{"key":"657_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26432","volume":"31","author":"J Pagonabarraga","year":"2016","unstructured":"Pagonabarraga, J. et al. Minor hallucinations occur in drug-naive Parkinson\u2019s disease patients, even from the premotor phase. Mov. Disord. 31, 45\u201352 (2016).","journal-title":"Mov. Disord."},{"key":"657_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mds.20263","volume":"20","author":"AD de Maindreville","year":"2005","unstructured":"de Maindreville, A. D., F\u00e9nelon, G. & Mahieux, F. Hallucinations in Parkinson\u2019s disease: a follow-up study. Mov. Disord. 20, 212\u2013217 (2005).","journal-title":"Mov. Disord."},{"key":"657_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8362","volume":"13","author":"F Bernasconi","year":"2021","unstructured":"Bernasconi, F. et al. Robot-induced hallucinations in Parkinson\u2019s disease depend on altered sensorimotor processing in fronto-temporal network. Sci. Transl. Med. 13, eabc8362 (2021).","journal-title":"Sci. Transl. Med."},{"key":"657_CR32","doi-asserted-by":"publisher","first-page":"923560","DOI":"10.3389\/fnagi.2022.923560","volume":"14","author":"M Zhong","year":"2022","unstructured":"Zhong, M. et al. Aberrant gray matter volume and functional connectivity in Parkinson\u2019s disease with minor hallucination. Front. Aging Neurosci. 14, 923560 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"657_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/ene.14576","volume":"28","author":"H Bejr-kasem","year":"2021","unstructured":"Bejr-kasem, H. et al. Minor hallucinations reflect early gray matter loss and predict subjective cognitive decline in Parkinson\u2019s disease. Eur. J. Neurol. 28, 438\u2013447 (2021).","journal-title":"Eur. J. Neurol."},{"key":"657_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/mds.29681","volume":"39","author":"K Baik","year":"2024","unstructured":"Baik, K. et al. Functional brain networks of minor and well-structured major hallucinations in Parkinson\u2019s disease. Mov. Disord. 39, 318\u2013327 (2024).","journal-title":"Mov. Disord."},{"key":"657_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/mds.27557","volume":"34","author":"H Bejr-kasem","year":"2019","unstructured":"Bejr-kasem, H. et al. Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson\u2019s disease. Mov. Disord. 34, 78\u201386 (2019).","journal-title":"Mov. Disord."},{"key":"657_CR36","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/nn.4135","volume":"18","author":"ES Finn","year":"2015","unstructured":"Finn, E. S. et al. Functional connectome fingerprinting: identifying individuals using patterns of brain connectivity. Nat. Neurosci. 18, 1664\u20131671 (2015).","journal-title":"Nat. Neurosci."},{"key":"657_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25089-1","volume":"8","author":"E Amico","year":"2018","unstructured":"Amico, E. & Go\u00f1i, J. The quest for identifiability in human functional connectomes. Sci. Rep. 8, 8254 (2018).","journal-title":"Sci. Rep."},{"key":"657_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25895-8","volume":"12","author":"J da Silva Castanheira","year":"2021","unstructured":"da Silva Castanheira, J., Orozco Perez, H. D., Misic, B. & Baillet, S. Brief segments of neurophysiological activity enable individual differentiation. Nat. Commun. 12, 5713 (2021).","journal-title":"Nat. Commun."},{"key":"657_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118254","volume":"239","author":"ES Finn","year":"2021","unstructured":"Finn, E. S. & Rosenberg, M. D. Beyond fingerprinting: choosing predictive connectomes over reliable connectomes. NeuroImage 239, 118254 (2021).","journal-title":"NeuroImage"},{"key":"657_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nn.4179","volume":"19","author":"MD Rosenberg","year":"2016","unstructured":"Rosenberg, M. D. et al. A neuromarker of sustained attention from whole-brain functional connectivity. Nat. Neurosci. 19, 165\u2013171 (2016).","journal-title":"Nat. Neurosci."},{"key":"657_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.4511","volume":"20","author":"T Kaufmann","year":"2017","unstructured":"Kaufmann, T. et al. Delayed stabilization and individualization in connectome development are related to psychiatric disorders. Nat. Neurosci. 20, 513\u2013515 (2017).","journal-title":"Nat. Neurosci."},{"key":"657_CR42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamapsychiatry.2018.0844","volume":"75","author":"T Kaufmann","year":"2018","unstructured":"Kaufmann, T. et al. Stability of the brain functional connectome fingerprint in individuals with schizophrenia. JAMA Psychiatry 75, 749\u2013751 (2018).","journal-title":"JAMA Psychiatry"},{"key":"657_CR43","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s44220-023-00151-8","volume":"1","author":"Z Fu","year":"2023","unstructured":"Fu, Z., Liu, J., Salman, M. S., Sui, J. & Calhoun, V. D. Functional connectivity uniqueness and variability? Linkages with cognitive and psychiatric problems in children. Nat. Ment. Health 1, 956\u2013970 (2023).","journal-title":"Nat. Ment. Health"},{"key":"657_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118253","volume":"238","author":"P Sorrentino","year":"2021","unstructured":"Sorrentino, P. et al. Clinical connectome fingerprints of cognitive decline. NeuroImage 238, 118253 (2021).","journal-title":"NeuroImage"},{"key":"657_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06829-8","volume":"7","author":"S Stampacchia","year":"2024","unstructured":"Stampacchia, S. et al. Fingerprints of brain disease: connectome identifiability in Alzheimer\u2019s disease. Commun. Biol. 7, 1169 (2024).","journal-title":"Commun. Biol."},{"key":"657_CR46","doi-asserted-by":"publisher","first-page":"105201","DOI":"10.1016\/j.ebiom.2024.105201","volume":"105","author":"J da Silva Castanheira","year":"2024","unstructured":"da Silva Castanheira, J. et al. The neurophysiological brain-fingerprint of Parkinson\u2019s disease. eBioMedicine 105, 105201 (2024).","journal-title":"eBioMedicine"},{"key":"657_CR47","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/hbm.26156","volume":"44","author":"E Troisi Lopez","year":"2022","unstructured":"Troisi Lopez, E. et al. Fading of brain network fingerprint in Parkinson\u2019s disease predicts motor clinical impairment. Hum. Brain Mapp. 44, 1239\u20131250 (2022).","journal-title":"Hum. Brain Mapp."},{"key":"657_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28087-0","volume":"13","author":"M Vignando","year":"2022","unstructured":"Vignando, M. et al. Mapping brain structural differences and neuroreceptor correlates in Parkinson\u2019s disease visual hallucinations. Nat. Commun. 13, 519 (2022).","journal-title":"Nat. Commun."},{"key":"657_CR49","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1001\/archneurol.2010.35","volume":"67","author":"B Ballanger","year":"2010","unstructured":"Ballanger, B. et al. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch. Neurol. 67, 416\u2013421 (2010).","journal-title":"Arch. Neurol."},{"key":"657_CR50","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1212\/WNL.0000000000006007","volume":"91","author":"MJ Firbank","year":"2018","unstructured":"Firbank, M. J. et al. Reduced occipital GABA in Parkinson disease with visual hallucinations. Neurology 91, e675\u2013e685 (2018).","journal-title":"Neurology"},{"key":"657_CR51","doi-asserted-by":"publisher","first-page":"fcae460","DOI":"10.1093\/braincomms\/fcae460","volume":"7","author":"L Pini","year":"2024","unstructured":"Pini, L., Lista, S., Griffa, A., Allali, G. & Imbimbo, B. P. Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs? Brain Commun. 7, fcae460 (2024).","journal-title":"Brain Commun."},{"key":"657_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41386-024-01962-8","volume":"50","author":"J Ramduny","year":"2024","unstructured":"Ramduny, J. & Kelly, C. Connectome-based fingerprinting: reproducibility, precision, and behavioral prediction. Neuropsychopharmacology 50, 114\u2013123 (2024).","journal-title":"Neuropsychopharmacology"},{"key":"657_CR53","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41380-019-0565-3","volume":"26","author":"NY Kim","year":"2021","unstructured":"Kim, N. Y. et al. Lesions causing hallucinations localize to one common brain network. Mol. Psychiatry 26, 1299\u20131309 (2021).","journal-title":"Mol. Psychiatry"},{"key":"657_CR54","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.parkreldis.2013.11.017","volume":"20","author":"J Pagonabarraga","year":"2014","unstructured":"Pagonabarraga, J. et al. Neural correlates of minor hallucinations in non-demented patients with Parkinson\u2019s disease. Parkinsonism Relat. Disord. 20, 290\u2013296 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"657_CR55","first-page":"820","volume":"4","author":"T Moberget","year":"2019","unstructured":"Moberget, T. & Ivry, R. B. Prediction, psychosis, and the cerebellum. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 4, 820\u2013831 (2019).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"657_CR56","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1016\/j.cub.2014.09.049","volume":"24","author":"O Blanke","year":"2014","unstructured":"Blanke, O. et al. Neurological and robot-controlled induction of an apparition. Curr. Biol. 24, 2681\u20132686 (2014).","journal-title":"Curr. Biol."},{"key":"657_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.parkreldis.2022.07.009","volume":"102","author":"H Bejr-Kasem","year":"2022","unstructured":"Bejr-Kasem, H. et al. The role of attentional control over interference in minor hallucinations in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 102, 101\u2013107 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"657_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48731-1","volume":"15","author":"N Rajamani","year":"2024","unstructured":"Rajamani, N. et al. Deep brain stimulation of symptom-specific networks in Parkinson\u2019s disease. Nat. Commun. 15, 4662 (2024).","journal-title":"Nat. Commun."},{"key":"657_CR59","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s42003-022-03903-x","volume":"5","author":"A Zarkali","year":"2022","unstructured":"Zarkali, A. et al. Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson\u2019s disease. Commun. Biol. 5, 928 (2022).","journal-title":"Commun. Biol."},{"key":"657_CR60","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/mds.23083","volume":"25","author":"P Huot","year":"2010","unstructured":"Huot, P. et al. Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations. Mov. Disord. 25, 1399\u20131408 (2010).","journal-title":"Mov. Disord."},{"key":"657_CR61","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/brcg.1995.1255","volume":"28","author":"EK Perry","year":"1995","unstructured":"Perry, E. K. & Perry, R. H. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn. 28, 240\u2013258 (1995).","journal-title":"Brain Cogn."},{"key":"657_CR62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/mdc3.13319","volume":"8","author":"J Pasquini","year":"2021","unstructured":"Pasquini, J., Brooks, D. J. & Pavese, N. The cholinergic brain in Parkinson\u2019s disease. Mov. Disord. Clinical Practice 8, 1012\u20131026 (2021).","journal-title":"Mov. Disord. Clinical Practice"},{"key":"657_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45912-w","volume":"15","author":"L Albert","year":"2024","unstructured":"Albert, L., Potheegadoo, J., Herbelin, B., Bernasconi, F. & Blanke, O. Numerosity estimation of virtual humans as a digital-robotic marker for hallucinations in Parkinson\u2019s disease. Nat. Commun. 15, 1905 (2024).","journal-title":"Nat. Commun."},{"key":"657_CR64","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1038\/s41596-022-00737-z","volume":"17","author":"F Bernasconi","year":"2022","unstructured":"Bernasconi, F. et al. Neuroscience robotics for controlled induction and real-time assessment of hallucinations. Nat. Protoc. 17, 2966\u20132989 (2022).","journal-title":"Nat. Protoc."},{"key":"657_CR65","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.neuron.2017.07.011","volume":"95","author":"EM Gordon","year":"2017","unstructured":"Gordon, E. M. et al. Precision functional mapping of individual human brains. Neuron 95, 791\u2013807 (2017).","journal-title":"Neuron"},{"key":"657_CR66","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"657_CR67","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"657_CR68","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.neuroimage.2011.10.018","volume":"59","author":"JD Power","year":"2012","unstructured":"Power, J. D., Barnes, K. A., Snyder, A. Z., Schlaggar, B. L. & Petersen, S. E. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. NeuroImage 59, 2142\u20132154 (2012).","journal-title":"NeuroImage"},{"key":"657_CR69","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neuroimage.2013.08.048","volume":"84","author":"JD Power","year":"2014","unstructured":"Power, J. D. et al. Methods to detect, characterize, and remove motion artifact in resting state fMRI. NeuroImage 84, 320\u2013341 (2014).","journal-title":"NeuroImage"},{"key":"657_CR70","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroimage.2017.01.020","volume":"148","author":"E Amico","year":"2017","unstructured":"Amico, E. et al. Mapping the functional connectome traits of levels of consciousness. NeuroImage 148, 201\u2013211 (2017).","journal-title":"NeuroImage"},{"key":"657_CR71","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.neuroimage.2013.05.081","volume":"82","author":"X Shen","year":"2013","unstructured":"Shen, X., Tokoglu, F., Papademetris, X. & Constable, R. T. Groupwise whole-brain parcellation from resting-state fMRI data for network node identification. NeuroImage 82, 403\u2013415 (2013).","journal-title":"NeuroImage"},{"key":"657_CR72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuroimage.2009.06.060","volume":"48","author":"DN Greve","year":"2009","unstructured":"Greve, D. N. & Fischl, B. Accurate and robust brain image alignment using boundary-based registration. NeuroImage 48, 63\u201372 (2009).","journal-title":"NeuroImage"},{"key":"657_CR73","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1152\/jn.00338.2011","volume":"106","author":"BTT Yeo","year":"2011","unstructured":"Yeo, B. T. T. et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J. Neurophysiol. 106, 1125\u20131165 (2011).","journal-title":"J. Neurophysiol."},{"key":"657_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116515","volume":"209","author":"E Amico","year":"2020","unstructured":"Amico, E. et al. The disengaging brain: dynamic transitions from cognitive engagement and alcoholism risk. NeuroImage 209, 116515 (2020).","journal-title":"NeuroImage"},{"key":"657_CR75","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1162\/netn_a_00049","volume":"2","author":"E Amico","year":"2018","unstructured":"Amico, E. & Go\u00f1i, J. Mapping hybrid functional-structural connectivity traits in the human connectome. Netw. Neurosci. 2, 306\u2013322 (2018).","journal-title":"Netw. Neurosci."},{"key":"657_CR76","doi-asserted-by":"publisher","first-page":"eabj0751","DOI":"10.1126\/sciadv.abj0751","volume":"7","author":"D Van De Ville","year":"2021","unstructured":"Van De Ville, D., Farouj, Y., Preti, M. G., Li\u00e9geois, R. & Amico, E. When makes you unique: temporality of the human brain fingerprint. Sci. Adv. 7, eabj0751 (2021).","journal-title":"Sci. Adv."},{"key":"657_CR77","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s42003-024-06829-8","volume":"7","author":"S Stampacchia","year":"2024","unstructured":"Stampacchia, S. et al. Fingerprinting of brain disease: connectome identifiability in Alzheimer\u2019s disease. Commun. Biol. 7, 1169 (2024).","journal-title":"Commun. Biol."},{"key":"657_CR78","doi-asserted-by":"crossref","unstructured":"McGraw, K. O. & Wong, S. P. Forming inferences about some intraclass correlation coefficients. Psychol. Methods 1, 30\u201346 (1996).","DOI":"10.1037\/1082-989X.1.1.30"},{"key":"657_CR79","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.neuroimage.2013.05.099","volume":"83","author":"RM Birn","year":"2013","unstructured":"Birn, R. M. et al. The effect of scan length on the reliability of resting-state fMRI connectivity estimates. NeuroImage 83, 550\u2013558 (2013).","journal-title":"NeuroImage"},{"key":"657_CR80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.dcn.2015.08.003","volume":"15","author":"K Somandepalli","year":"2015","unstructured":"Somandepalli, K. et al. Short-term test\u2013retest reliability of resting state fMRI metrics in children with and without attention-deficit\/hyperactivity disorder. Dev. Cogn. Neurosci. 15, 83\u201393 (2015).","journal-title":"Dev. Cogn. Neurosci."},{"key":"657_CR81","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/cercor\/bhn256","volume":"19","author":"Z Shehzad","year":"2009","unstructured":"Shehzad, Z. et al. The resting brain: unconstrained yet reliable. Cereb. Cortex 19, 2209\u20132229 (2009).","journal-title":"Cereb. Cortex"},{"key":"657_CR82","doi-asserted-by":"publisher","first-page":"e00456","DOI":"10.1002\/brb3.456","volume":"6","author":"LM Shah","year":"2016","unstructured":"Shah, L. M., Cramer, J. A., Ferguson, M. A., Birn, R. M. & Anderson, J. S. Reliability and reproducibility of individual differences in functional connectivity acquired during task and resting state. Brain Behav. 6, e00456 (2016).","journal-title":"Brain Behav."},{"key":"657_CR83","doi-asserted-by":"publisher","first-page":"116157","DOI":"10.1016\/j.neuroimage.2019.116157","volume":"203","author":"S Noble","year":"2019","unstructured":"Noble, S., Scheinost, D. & Constable, R. T. A decade of test\u2013retest reliability of functional connectivity: a systematic review and meta-analysis. NeuroImage 203, 116157 (2019).","journal-title":"NeuroImage"},{"key":"657_CR84","first-page":"127","volume":"86","author":"DV Cicchetti","year":"1981","unstructured":"Cicchetti, D. V. & Sparrow, S. A. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am. J. Ment. Defic. 86, 127\u2013137 (1981).","journal-title":"Am. J. Ment. Defic."},{"key":"657_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068910","volume":"8","author":"M Xia","year":"2013","unstructured":"Xia, M., Wang, J. & He, Y. BrainNet viewer: a network visualization tool for human brain connectomics. PLoS ONE 8, e68910 (2013).","journal-title":"PLoS ONE"},{"key":"657_CR86","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/mds.25568","volume":"28","author":"R Fern\u00e1ndez de Bobadilla","year":"2013","unstructured":"Fern\u00e1ndez de Bobadilla, R. et al. Parkinson\u2019s disease-cognitive rating scale: psychometrics for mild cognitive impairment. Mov. Disord. 28, 1376\u20131383 (2013).","journal-title":"Mov. Disord."},{"key":"657_CR87","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/s41592-022-01625-w","volume":"19","author":"RD Markello","year":"2022","unstructured":"Markello, R. D. et al. neuromaps: structural and functional interpretation of brain maps. Nat Methods 19, 1472\u20131479 (2022).","journal-title":"Nat Methods"},{"key":"657_CR88","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuroimage.2012.07.001","volume":"63","author":"M Savli","year":"2012","unstructured":"Savli, M. et al. Normative database of the serotonergic system in healthy subjects using multi-tracer PET. NeuroImage 63, 447\u2013459 (2012).","journal-title":"NeuroImage"},{"key":"657_CR89","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00259-017-3645-0","volume":"44","author":"S Kaller","year":"2017","unstructured":"Kaller, S. et al. Test\u2013retest measurements of dopamine D1-type receptors using simultaneous PET\/MRI imaging. Eur. J. Nucl. Med. Mol. Imaging 44, 1025\u20131032 (2017).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"657_CR90","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/jcbfm.2015.53","volume":"35","author":"K Alakurtti","year":"2015","unstructured":"Alakurtti, K. et al. Long-term test\u2013retest reliability of striatal and extrastriatal dopamine D2\/3 receptor binding: study with [11C]raclopride and high-resolution PET. J. Cereb. Blood Flow Metab. 35, 1199\u20131205 (2015).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"657_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22444-0","volume":"8","author":"J Dukart","year":"2018","unstructured":"Dukart, J. et al. Cerebral blood flow predicts differential neurotransmitter activity. Sci. Rep. 8, 4074 (2018).","journal-title":"Sci. Rep."},{"key":"657_CR92","doi-asserted-by":"publisher","unstructured":"Naganawa, M. et al. First in human assessment of the novel M1 muscarinic acetylcholine receptor PET radiotracer 11C-LSN3172176. J. Nucl. Med. https:\/\/doi.org\/10.2967\/jnumed.120.246967 (2020).","DOI":"10.2967\/jnumed.120.246967"},{"key":"657_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuroimage.2016.07.026","volume":"141","author":"AT Hillmer","year":"2016","unstructured":"Hillmer, A. T. et al. Imaging of cerebral \u03b14\u03b22* nicotinic acetylcholine receptors with (\u2212)\u2212[18F]Flubatine PET: implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain. NeuroImage 141, 71\u201380 (2016).","journal-title":"NeuroImage"},{"key":"657_CR94","unstructured":"R: a language and environment for statistical computing. https:\/\/www.R-project.org\/ (R Core Team, 2020)."},{"key":"657_CR95","unstructured":"MATLAB (The MathWorks Inc., 2022)."},{"key":"657_CR96","doi-asserted-by":"crossref","unstructured":"Frossard, J. & Renaud, O. Permutation tests for regression, ANOVA, and comparison of signals: the permuco package. J. Stat. Soft. 99, 1\u201332 (2021).","DOI":"10.18637\/jss.v099.i15"},{"key":"657_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118331","volume":"240","author":"E Sareen","year":"2021","unstructured":"Sareen, E. et al. Exploring MEG brain fingerprints: evaluation, pitfalls, and interpretations. NeuroImage 240, 118331 (2021).","journal-title":"NeuroImage"}],"container-title":["Nature Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44220-026-00657-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44220-026-00657-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44220-026-00657-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:03:08Z","timestamp":1791572588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44220-026-00657-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":97,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["657"],"URL":"https:\/\/doi.org\/10.1038\/s44220-026-00657-x","relation":{},"ISSN":["2731-6076"],"issn-type":[{"value":"2731-6076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was originally published under the subscription model but it is now published under an Open Access license.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.B. is inventor on patent US 10,286,555 B2 held by the Swiss Federal Institute of Technology (EPFL) that covers the robot-controlled induction of presence hallucination. O.B. is inventor on patent US 10,349,899 B2 held by the EPFL that covers a robotic system for the prediction of hallucinations for diagnostic and therapeutic purposes. O.B. and F.B. are inventors on US Patent Application 19\/127,963 held by the EPFL for predicting a prognosis of the neuropsychological and\/or neuropsychiatric status. O.B. is a member of the board and shareholder of Mindmaze Therapeutics SA. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}